|Last Price ||Today's Change || Day's Range || Trading Volume |
|4.90 || +0.11 (2.30%) || 4.77 - 5.00 || 23,400 |
 Click the icon table to view the Meeting detail page.
Click here to modify the Visible Columns.
|Ann. Date ||Date ||Time ||Type ||Venue ||View |
| 11-Mar-2013 || 03-Apr-2013 || 10:00 || EGM || The Royale Bintang Damansara Hotel, The Royale Ballroom, 2nd Floor, No. 2 Jalan PJU 7/3, Mutiara Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan || |
| 15-Mar-2013 || 03-Apr-2013 || 09:30 || AGM || The Royale Bintang Damansara Hotel, The Royale Ballroom, 2nd Floor, No. 2 Jalan PJU 7/3, Mutiara Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan || |
| 10-Mar-2014 || 02-Apr-2014 || 10:00 || AGM || The Royale Chulan Damansara Hotel (formerly known as "The Royale Bintang Damansara Hotel"), The Royale Ballroom, 2nd Floor, No. 2, Jalan PJU 7/3, Mutiara Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan || |
| 06-Mar-2015 || 31-Mar-2015 || 10:00 || AGM || The Royale Chulan Damansara Hotel
The Royale Ballroom, 2nd Floor
No. 2, Jalan PJU 7/3, Mutiara Damansara
47810 Petaling Jaya
Selangor Darul Ehsan. || |
| 08-Mar-2016 || 29-Mar-2016 || 10:30 || EGM || The Royale Chulan Damansara Hotel, The Royale Ballroom, Level 2, No. 2, Jalan PJU 7/3, Mutiara Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan || |
| 22-Mar-2016 || 29-Mar-2016 || 09:30 || AGM || The Royale Chulan Damansara Hotel, The Royale Ballroom, Level 2, No. 2, Jalan PJU 7/3, Mutiara Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan || |
| 14-Mar-2017 || 06-Apr-2017 || 09:00 || AGM || The Royale Chulan Damansara Hotel, Mutiara Ballroom, Ground Floor, No. 2, Jalan PJU 7/3, Mutiara Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan || |
limayseng can't imagine Pharma making a loss in the 4th quarter in 2013,2014 and 2015?
billionchew high dividend, will up again tomorrow....7.50 to 8 is possible.
Rica7894 The biggest distributor of medical products to Malaysia's MOH .
>>>>>>>>A strong defensive play support by decent yield!<<<<<<<<
>>>>>>>> A safe haven for investors given its recession proof nature!<<<<<<<<
--Best-known as the biggest distributor of medical products to Malaysia's MOH (Ministry of Health), supplying 50% of the Ministry's needs.
-4Q should be stronger. Expect sales to recover in 4Q as MOH’s hospitals and clinics replenish their inventories.
-Earnings growth for Pharmaniaga should remain resilient despite the presence of rising costs pressures, subdued consumer sentiment and economic uncertainty.
-Valuation is considerably attractive compared to other pharmaceutical-related stocks. Expects higher contribution from its Indonesia and non-concession segment in 2016.
-Decent dividend yield between 4.8% to 5%.
*****Earnings driver for the group would be:*****
(a)Contribution from its three teaching hospitals;
(b)European Union Good Manufacturing certification which would provide the group with stronger footing in European market. Pharmaniaga could see another period of strong earnings growth in 2016 (+33% yoy to RM116m) as its small-volume injectable (SVI) plant should receive approvals from the EU authorities for the sale of its SVI products to the EU market by then.
(c)Beneficiary of patent cliff . The group is also set to benefit from a "patent cliff" − the expiry of patents for bestselling drugs with US$133bn annual sales worldwide over the next 3 years. The patent cliff will allow generic drug makers such as Pharmaniaga to enter once-protected segments of the pharmaceutical market via the introduction of generic versions of the patented drugs;
(d)Growth exposure in the healthcare and pharmaceutical industry supported by an ageing population.
(e)Concession agreement (CA) is the jewel in the crown. Defensive earnings as the sole concession holder to purchase, store, supply and distribute drugs and medicinal products to 148 government hospitals and 1,400 clinics, The concession agreement ends in Nov 2019 and allows for upwards revision in prices every three years.
(f)To benefit from the RM4.6bn allocation stated in Budget 2016 to supply medicines, consumables, vaccines and reagents to all government hospitals and clinics.
SingInvestor Hi, today 3.8 lots all brought by you?
Liau San announced 0.07cents dividen today.
Rica7894 Below expectations due to higher amortization for its Pharmacy Information System of Rm26.4m(PhIS) and lower than expected government orders. PBT declined 10.4% to RM112.5m.
Pharmaniaga’s manufacturing division charted higher PBT by 17% (FY15: RM109.5m vs. FY14: RM93.7m) resulting from better productivity and efficiency as well as cost management.
Pharmaniaga has spent c.RM170m to install the PhIS in government hospitals. This amount was capitalised and will be amortised over the tenure of its concession agreement (expires in Nov 2019).
FY16 earnings could remain unexciting due to:
-Sales growth could be capped by the government’s budget recalibration.
-The amortisation charges related to the PhIS will continue to suppress its profit margin.
Amit Khindriya Financial statements already showing cash flow issues. Drawdown rm200m to pay dividend. Time to run
billionchew dun panic! just hold, high D/Y, 7.00 is possible.
SingInvestor Yes. Buy and hold as I now make it my FD. :)
ruby828 At wat price to buy. Hope i dun catch a falling knife....
Chinkang i think today is the chance to buy. High dividend, can hold for long.
i think healthcare/ medic sector will be very strong in the future.
its my own view only. :)
Chinkang B19. Prospects
While external economic pressures will continue to persist in 2016, there are bright prospects for the pharmaceutical sector that the Group is well positioned to tap into. A clear reflection of this are the initiative outlined in the National Budget 2016, which include a higher allocation for vaccines and medicines, an increase in the number of GST zero-rated medicines, as welll as more clinics and hospitals to be built nationwide.
In addition, the group aims to expand it's presence in the European Union via it's product portfolio, which is undergoing the necessary review and registration process. It also intends to mould it's Indonesian manufacturing subsidiary into and important manufacturing and export hub for the ASEAN region.
The Group is focused on leveraging on these opportunities by enhancing and diversifying its products and services to meet the growing needs of the healthcare industry, both in Malaysia and International markets.
leecuteguy external economic pressures will only make more people to do panic selling.........people will not think much of fundamental for this counter....no doubt, price will drop if panic selling happen
ruby828 think this counter is ok.....but i dunno whether now is a good time to enter?
ruby828 Chinkang, thanxs for the info and advice.
Chinkang @ruby that's just my opinion. Based on the historical charts, share price will dropped after dividend entitlement date then it will increase back, however pharma is walking down trend recently.
For short term, shouldn't consider this company, for long term, yes.
Asia88 Let throw Tan Sri out of office. He is Chairman of 1MDB( questionable entity). Share price drop so much.
ruby828 if break 5.70.....it might go down to 5.40......:)
SingInvestor ruby your dream price coming soon.....5.40....Good.!!!!
ruby828 iya...y rebound so soon...
CUTLOST Hope will rebound soon to 5.70
billionchew sure rebound, keep hold & keep confident, dun worry!
tuapuikia I made many from this counter. but not sure it is good to in now
shortinvestor77 Yes, of course. The management will solve the operating cost high problem. See the revenue keeps increasing. Likewise for dividends. One time profit down does mean it will always down. Refer to Media as an example.I got only 2000 units. Thinking of buy more.
shortinvestor77 Increasing profit by:
ACQUISITION OF ADDITIONAL 383,328 ORDINARY SHARES (OR 10% SHAREHOLDING) IN THE SUBSIDIARY, PT ERRITA PHARMA BY PHARMANIAGA INTERNATIONAL CORPORATION SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF PHARMANIAGA BERHAD
Bob Barley Tppa will affect this market?
Chinkang 13mil shares trade at 6.26
891088 Buy now b4 too late
shortinvestor77 Revenue increases but net profit decreases. Pro and con. 5 cents div is good.
NavinShah Kayu directors jadi kaya lah. Sumua masuk koche lah.
ruskymee It hits the 52 weeks lowest price. Should consider to buy some for long term investment.
supergreat should sell phamaniaga and switch to kotra pharma or ccmbio
jibbie everyday keep dropping.. when will it hit rock bottom?
jibbie should be rock bottom now and safe to enter.